Tag: BioDelivery Sciences
February 18, 2018
5 Top NASDAQ Biotech Stocks: HTG in the Lead This Week
This past week the NASDAQ Biotechnology Index increased by 4.15 percent reaching 3,501.80 points in the last week—nearly equal to... February 6, 2018
BioDelivery Sciences Announces BELBUCA® Patent Litigation Settlement Agreement with Teva
BioDelivery Sciences (NASDAQ:BDSI) announced that it has entered into a Settlement Agreement with Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals... January 30, 2018
BioDelivery Sciences Announces Launch and Availability of BELBUCA® in Canada
BioDelivery Sciences International (NASDAQ:BDSI) and Purdue Pharma announced today that BELBUCA® (buprenorphine) buccal film is now commercially available in Canada.... January 21, 2018
5 Top NASDAQ Biotech Stocks: Galectin Top Biotech Stock So Far in 2018
Catalyst Biosciences, Adverum Biotechnologies, MannKind, Galectin Therapeutics and Aptose Biosciences topped last week's NASDAQ biotech stock list. December 10, 2017
5 Top NASDAQ Biotech Stocks: Viking Therapeutics Leads the Week
Viking Therapeutics, Second Sight Medical Products, Ekso Bionics Holdings, Ohr Pharmaceutical and Cardiome Pharma topped last week's NASDAQ biotech stock list. November 26, 2017
5 Top NASDAQ Biotech Stocks: CASI Pharmaceuticals Leads The Pack This Week
CASI Pharmaceuticals, Neptune Tech & Bioresource, Vermilion, Trillium Therapeutics and Xoma topped last week's NASDAQ biotech stock list. November 12, 2017